The proposed bill, known as the Chemical Abortion Safety Protocol Act, aims to establish specific protocols and requirements for the provision of abortion-inducing drugs in Nebraska. It includes definitions for key terms such as "abortion-inducing drug" and "adverse event," and mandates that physicians must conduct an in-person examination of the woman, verify her pregnancy, and assess for ectopic pregnancies before providing such drugs. Additionally, the bill requires physicians to schedule a follow-up visit within a specified timeframe to confirm the termination of pregnancy and document any adverse events that may occur.

Furthermore, the bill amends existing law regarding unprofessional conduct for physicians by adding violations of the Chemical Abortion Safety Protocol Act to the list of unprofessional conduct. It also includes provisions for reporting requirements to the Department of Health and Human Services, ensuring that reports do not contain personally identifying information about the women involved. The bill emphasizes the severability of its provisions, meaning that if any part is found unconstitutional, the remaining sections will still be valid. The original section of the law being amended is repealed as part of this legislative update.

Statutes affected:
Introduced: 38-2021